HighTower Advisors’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,528
Closed -$256K 3190
2022
Q2
$256K Buy
1,528
+17
+1% +$2.59K ﹤0.01% 2461
2022
Q1
$280K Sell
1,511
-3
-0.2% -$621 ﹤0.01% 2577
2021
Q4
$406K Sell
1,514
-687
-31% -$180K ﹤0.01% 2291
2021
Q3
$642K Buy
2,201
+90
+4% +$26.3K ﹤0.01% 1905
2021
Q2
$523K Sell
2,111
-167
-7% -$42.9K ﹤0.01% 2023
2021
Q1
$652K Buy
2,278
+848
+59% +$338K ﹤0.01% 1813
2020
Q4
$400K Buy
1,430
+303
+27% +$112K ﹤0.01% 1746
2020
Q3
$459K Sell
1,127
-433
-28% -$222K ﹤0.01% 1615
2020
Q2
$905K Buy
1,560
+467
+43% +$213K ﹤0.01% 1174
2020
Q1
$250K Sell
1,093
-3,307
-75% -$573K ﹤0.01% 1663
2019
Q4
$118K Buy
4,400
+67
+2% +$1.98K ﹤0.01% 2066
2019
Q3
$134K Hold
4,333
﹤0.01% 2136
2019
Q2
$107K Buy
4,333
+500
+13% +$14K ﹤0.01% 2154
2019
Q1
$122K Buy
3,833
+700
+22% +$25.2K ﹤0.01% 2042
2018
Q4
$138K Buy
3,133
+548
+21% +$35.8K ﹤0.01% 1911
2018
Q3
$204K Hold
2,585
﹤0.01% 1948
2018
Q2
$301K Sell
2,585
-716
-22% -$58.4K ﹤0.01% 1683
2018
Q1
$216K Buy
3,301
+50
+2% +$3.82K ﹤0.01% 1835
2017
Q4
$265K Buy
3,251
+956
+42% +$143K ﹤0.01% 1764
2017
Q3
$430K Buy
+2,295
New +$351K ﹤0.01% 1505

Other funds holding CODX

HighTower Advisors's CODX Position: Q3 2022 in Review

HighTower Advisors sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 1,528 shares — an estimated $256K sold.

HighTower Advisors first reported a position in CODX in Q3 2017 and held it in 20 quarters. The position peaked at $905K in Q2 2020. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

  • HighTower Advisors reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 1,528 Co-Diagnostics shares in Q3 2022, an estimated $256K.
  • HighTower Advisors first reported a position in Co-Diagnostics in Q3 2017 and held it in 20 quarters.
  • HighTower Advisors's Co-Diagnostics position peaked at $905K in Q2 2020.
  • 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.